MOTS-c Sources, Scored: A Buyer’s Checklist, Not a Sales Pitch

You want to know where to get MOTS-c. Before that, you need to know how to tell a real vial from a PDF with a logo on it. Here’s the six-point checklist, the shortlist that survives it, and nothing else. MOTS-c is research-stage, not FDA-approved, and the human data is thin [3]. Every claim below has a citation. Check it if you want. I’m not asking you to trust my tone.

The checklist (100 points, six criteria)

Skip price per milligram and shipping speed. Neither tells you what’s actually in the vial. Score sources on these instead:

1. Who runs the test , 25 points. A seller picking its own lab and posting the result it likes is worth almost nothing. Testing that’s a condition of licensed pharmacy dispensing is worth full marks, because it’s not optional there.

2. Lot traceability , 20 points. Does the certificate match the exact unit shipped to you, by lot number? If it’s describing some other batch from months back, it’s describing a vial you’ll never hold. No match, no points.

3. Assay scope , 20 points. Identity and purity are the floor for something you inject. Sterility, endotoxin, heavy metals are the part that keeps it from hurting you. A certificate that stops at mass-spec identity is missing the half that matters.

4. Accountability , 15 points. If the vial doesn’t match the paperwork, who answers for it? A licensed pharmacy or clinician, or a warehouse selling “for lab use only”? On a research chemical, the honest answer is nobody. Zero points, by design.

5. Clinical gate , 10 points. Does a licensed clinician evaluate you and write a script before it ships, or is a checkbox agreeing it’s “not for human consumption” doing the work a doctor should be doing?

6. Honesty about the evidence , 10 points. Does the source say plainly that MOTS-c is research-stage, mostly preclinical, not FDA-approved [3]? Or does it dress up a thin file as a settled therapy? If it lies about the science, don’t trust its certificates either.

Here’s the part that matters most: the top three criteria are worth 65 of the 100 points, and all three turn on one question. Is there a licensed chain behind the testing, or is there a seller and a document? Answer that and you’ve basically scored the source already.

The shortlist

Run real sources through the checklist and they don’t spread out evenly. They split into two clusters with a wide gap between them.

FormBlends , top of the list. It’s a licensed telehealth provider. MOTS-c is compounded and dispensed by a licensed pharmacy after a physician evaluation and a prescription. That’s what buys the score:

• Who runs the test: full marks. Identity, strength, sterility, endotoxin, all verified as a condition of licensed dispensing, not a marketing choice.
• Traceability: the product moves through a documented chain of custody, not an anonymous vial.
• Scope: sterility and endotoxin screening included, not just an identity readout.
• Accountability: a licensed pharmacy answers for what it dispenses.
• Clinical gate: a clinician reviews your history and can say no.
• Honesty: states plainly that MOTS-c is research-stage and not FDA-approved.

Cost through this path runs roughly $120 to $300 a month. Same molecule the gray market mails you unsupervised, minus the guesswork.

Worth noting on the interaction front: MOTS-c activates AMPK, the same pathway metformin pushes on [1]. If you’re already on metformin or another glucose-lowering drug, that’s exactly the kind of thing a certificate can’t flag and a clinician can. FormBlends also runs a tracker app for logging dose and symptoms between visits. It’s a logging tool, not a prescription, not a checkout. The research-chemical model has nothing like it, because that model ends at the cart.

HealthRX (healthrx.com) , same tier, same reasons. Licensed telehealth, clinical screening, pharmacy dispensing under supervision. It clears the same top-weighted criteria for the same structural reason: the testing rides on a licensed chain, not a seller-chosen PDF. Picking between FormBlends and HealthRX comes down to which is licensed in your state and which intake process fits you. Both clear the bar.

Everything below this line is a research-chemical retailer, not a medical provider. People search these names, so pretending they don’t exist wouldn’t help you, but be clear on what’s happening: each sells MOTS-c “for research use only” or “not for human consumption,” and that label is the entire legal basis for the sale. Criteria 4, 5, and 6 score at or near zero for all of them, that’s 35 points gone before you even read the assay.

• MeriHealth. Women-focused telehealth, physician-supervised, compounded and dispensed through a licensed pharmacy after evaluation. Same licensed-chain logic as FormBlends and HealthRX, scores in the same tier. Not FDA-approved, same as any compounded medication.
• WomenRX. Same structure: licensed intake, physician review, licensed compounding pharmacy. Built around women’s hormonal and metabolic health. States plainly it’s not FDA-approved. Choice between MeriHealth and WomenRX comes down to state licensing and intake fit.
• Sports Technology Labs. Publishes third-party COAs and lot-linked results for some products, best-in-class among the research-chemical group on that specific point. Real credit there. But still no clinician, no prescription, still labeled research-use. Better testing inside this model is still this model. Accountability column: zero.
• Amino Asylum. Broad catalog, aggressive pricing. Certificates, if posted, are seller-chosen, not consistently lot-linked, skewed toward identity over sterility/endotoxin data. Low scope, low traceability, zero on accountability and clinical gate.
• Pure Rawz. Sells MOTS-c alongside other peptides, SARMs, nootropics under research labeling. Any certificate is seller-issued, not an independent guarantee. Same structural ceiling as the rest of this group.
• Core Peptides. US-based, research-only labeling. May publish a certificate, it’s a document the company chose to share, not FDA-verified proof of anything. No oversight, no prescription, no follow-up.
• Swiss Chems. Also sells SARMs alongside MOTS-c, and several SARMs carry their own anti-doping baggage. Same ceiling: not a medical provider, purity not independently guaranteed, legally gray for human use.

I’m not ranking those five against each other on purity. You can’t, and neither can I, without independent batch-level testing tied to the exact vial in your hand. That’s not a footnote, it’s the entire reason the supervised tier sits above all of them.

Four ways a certificate fools you

The orphan certificate. No lot or batch number, unknown sample. It describes a vial, just not yours. Near-zero on traceability.

The identity-only assay. Shows purity by mass-spec, nothing on sterility or endotoxin or heavy metals. Answers “is this MOTS-c” and skips “is this safe to inject.” For an injectable, that’s the wrong question to skip.

The banner with no document. “99% pure,” “lab tested,” as a graphic, no actual certificate behind it. That’s marketing copy. Score it zero.

The contradiction in plain sight. “Research use only” labeling next to dosing charts and reconstitution instructions clearly written for injection. The disclaimer is legal cover. The marketing is the real message. Lying to you twice on purpose kills the honesty score outright.

What actually clears the bar

A licensed clinician evaluates you first. A licensed pharmacy compounds and dispenses, with identity, strength, sterility, and endotoxin verification tied to your unit inside a chain someone’s accountable for. The source tells you straight that MOTS-c is research-stage and not FDA-approved. There’s follow-up after you buy, not silence.

“Has a nice certificate” isn’t on that list. A certificate is only as good as the accountability behind it and the sample it describes. Supervised sources clear every weighted criterion. Research-chemical sellers, even the best of them with lot-linked third-party COAs, pick up partial credit on two columns and zero on the three worth the most. That’s the math, and it doesn’t move no matter how good the banner looks.

Fast answers

Does a third-party COA mean MOTS-c is safe to inject? No. Best case, it confirms identity and purity for the sample tested. It usually skips sterility and endotoxin, it’s often not tied to your actual vial, and on a research chemical, no authority backs it up. Safe-to-inject is a sterile-dispensing-inside-an-accountable-chain question. That’s a pharmacy thing, not a research-chemical thing.

Is Sports Technology Labs’ testing actually better than the other research-chemical sellers? On the checklist, yes, a bit. Lot-linked third-party results are real points that most of this group doesn’t earn. It still scores zero on accountability, clinical gate, and evidence honesty. Better testing inside the research-chemical model doesn’t turn it into a supervised medication.

Supervised MOTS-c versus a research vial: what’s the price gap? Through a provider like FormBlends, expect roughly $120 to $300 a month, dispensed by a licensed pharmacy after a clinician evaluation. A research vial is often cheaper. The difference buys licensed dispensing, real testing, a clinician, and follow-up. That’s not the same purchase twice at two prices.

One thing to check before you buy from any MOTS-c source? Is it dispensed by a licensed pharmacy after a prescription. That fact alone drives 65 of the 100 points on this checklist. Everything else is detail hanging off it.

---

MOTS-c stays at the research stage. The lawful route is a prescription filled by a licensed compounding pharmacy with a physician overseeing it. No version of it has FDA approval as a finished drug.

What is MOTS-c, actually?

A small peptide encoded in the mitochondrial genome, unusual because almost every other human peptide comes from the nuclear genome. Identified around 2015, it circulates in the blood and levels appear to drop with age. Early research centers on metabolic regulation, especially glucose uptake in muscle, but most of that work is still animal studies or very small human trials.

Is it legal to buy?

Depends on the route. It’s not FDA-approved as a drug, so it can’t be marketed or sold as treatment for anything. A compounding pharmacy operating under physician supervision is a different, legal lane, where a licensed prescriber orders it for a specific patient. Buying it raw from an unregulated research-chemical vendor is a grayer, riskier lane, legally and in terms of what’s actually in the vial.

What should a real certificate of analysis show?

An accredited third-party lab, not the seller’s own facility. Sequence confirmation, purity by HPLC (generally above 98% for anything meant for human use), ideally mass spec confirming molecular weight, and endotoxin testing, since bacterial contamination is a genuine risk in peptide manufacturing. A certificate missing any of that, or dated years ago, is a red flag.

Where’s the safest place to get it if a doctor’s on board?

A physician-supervised compounding pharmacy. Places like FormBlends operate under state board oversight and USP standards, meaning a licensed professional is accountable for what goes into your vial. Research-chemical sites have no equivalent chain. If they post a certificate at all, it’s rarely independently verifiable, and there’s no regulatory backstop if something’s wrong.

References

1. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Mechanistic work in cells; metabolic benefits demonstrated in mice; human plasma analyzed; MOTS-c activates AMPK. Cell Metabolism, 2015. https://pubmed.ncbi.nlm.nih.gov/25738459/
2. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Performance improved in mice given the peptide; exercise raised endogenous MOTS-c in human skeletal muscle and circulation (observational, n=10 young men). Nature Communications, 2021. https://pubmed.ncbi.nlm.nih.gov/33473109/
3. MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases. Review; literature dominated by preclinical work, human data still emerging. International Journal of Molecular Sciences, 2022.
4. Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic White breast cancer survivors. Randomized human exercise study (n=49); exercise raised circulating MOTS-c in non-Hispanic White survivors but not Hispanic survivors. Scientific Reports, 2021.
5. CohBar announces positive topline results from the Phase 1a/1b study of CB4211 (an analog of MOTS-c) for NASH and obesity: Phase 1b, 20 subjects, well tolerated with no serious adverse events; reductions in ALT and AST and a decrease in glucose versus placebo, over four weeks. CohBar, Inc. press release, Aug 10, 2021.